Romiplostim
Top View
- Oncology Drug Reference Guide
- Nplate) Reference Number: CP.PHAR.179 Effective Date: 03.01.16 Last Review Date: 02.21 Coding Implications Line of Business: Commercial, HIM, Medicaid Revision Log
- NPLATE (Romiplostim) for Injection, for Subcutaneous Use ------CONTRAINDICATIONS ------ Initial U.S
- Romiplostim for Severe Thrombocytopenia in the Treatment of Chronic Hepatitis C Virus Infection: a New Option for Clinicians?
- We Know How Hard the First Step Can Be
- Mitigative E Cacy of the Clinical Dosage Administration of Granulocyte
- The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin
- Lumicera Specialty Drug List
- The Thrombopoietin Mimetic Romiplostim Leads to the Complete Rescue of Mice Exposed to Lethal Ionizing Radiation
- Brand Generic Guide
- 07 Poster Viewing I 65..65
- The Role of Eltrombopag and Romiplostim As The
- Romiplostim Promotes Platelet Recovery in a Mouse Model of Multicycle Chemotherapy-Induced Thrombocytopenia Patricia L
- Phc P & T Additions, Changes & Deletions: P & T Committee
- PRESCRIBING INFORMATION After Suspected Or Confirmed Exposure to Myelosuppressive Doses of These Highlights Do Not Include All the Information Needed to Use Radiation
- Chemotherapy-Induced Myelosuppression in Patients with Small Cell Lung Cancer: What’S New?
- List of Drugs That Are Included in the Program
- 129-5-1. Prior Authorization. (A) Any Medical Service May Be Placed by The